BHCM
BVS icon

Brevan Howard Capital Management’s Bioventus BVS Stock Holding History

Brevan Howard Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,110
Closed -$142K – 2170
2025
Q4 		$142K Buy
+19,110
New +$137K ﹤0.01% 1641
2024
Q2 		– Sell
-18,613
Closed -$96.8K – 1087
2024
Q1 		$96.8K Buy
+18,613
New +$91K ﹤0.01% 896

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brevan Howard Capital Management's BVS Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Bioventus (BVS) in Q1 2026, closing a stake of 19,110 shares — an estimated $142K sold.

Brevan Howard Capital Management first reported a position in BVS in Q1 2024 and held it in 2 quarters. The position peaked at $142K in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 19,110 Bioventus shares in Q1 2026, an estimated $142K.
  • Brevan Howard Capital Management first reported a position in Bioventus in Q1 2024 and held it in 2 quarters.
  • Brevan Howard Capital Management's Bioventus position peaked at $142K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.